Winton Group LTD Repligen Corp Transaction History

Winton Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$49.45 - $62.8 $4.95 Million - $6.29 Million	-100,085 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$48.26 - $68.88 $4.83 Million - $6.89 Million	100,085 New	100,085 $5.28 Million
Q3 2018 Nov 02, 2018	SELL	$46.8 - $58.97 $265,964 - $335,126	-5,683 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$35.26 - $47.04 $107,119 - $142,907	-3,038 Reduced 34.84%	5,683 $0
Q1 2018 May 21, 2018	BUY	$30.92 - $37.27 $269,653 - $325,031	8,721 New	8,721 $0

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.